Sunday, October 30, 2022

CAR- T therapy for highly aggressive B cell lymphoma

Axicel versus tiso cel:

Axi cel with better PFS, and OS than tiso cel when compared in patients who did not go on trial. More grade 3 ICANS with Axicel.

https://www.nature.com/articles/s41591-022-01969-y

Lisocel has a better toxicity profile than Axicel, although premed with steroids helps reduce the incidence of CRS with axicel.



RTP Pan Pacific 2022

https://www.researchtopractice.com/UNMCPanPacific22CART/Video/1?playlistIndex=0#t=3m46s


No comments:

Post a Comment

Primary CNS lymphoma

 Reference: Annals of Oncology  June 2024 ESMO guidelines Diagnosis  Recommendations • Contrast-enhanced cranial MRI is the recommended imag...